IMARA Inc.
IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas. IMARA Inc. was incorporated in 2016 and is headquartered in Boston, Massachusetts. Show More...
-
Website https://imaratx.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 45.84 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-12 2011-12 2012-12 2013-12 2014-12 2015-12 2016-12 2017-12 2018-12 2019-12 TTM Earnings Per Share USD -1.2 -2.48 -2.07 Dividends USD Payout Ratio % * Shares Mil 9.0 9.0 17.0 Book Value Per Share * USD 6.09 Free Cash Flow Per Share * USD Return on Assets % -147.14 -114.45 -31.13 Financial Leverage (Average) 1.15 1.05 Return on Equity % -32.65 Return on Invested Capital % -33.32 Interest Coverage Current Ratio 4.21 7.29 22.19 Quick Ratio 4.03 6.89 21.39 Debt/Equity